EN
HI
Summary
As of 2 Oct, 2026, Venmax Drugs And Pharmaceuticals stock price is ₹14.76. During the trading session, the stock has moved between an intraday low of ₹14.11 and an intraday high of ₹15.00. Over the last 52 weeks, Venmax Drugs And Pharmaceuticals has traded between ₹12.71 and ₹31.49.
The stock has recorded a trading volume of 1,380 shares,. Its Average Traded Price (ATP) is ₹14.56, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹14.76.
Venmax Drugs And Pharmaceuticals has an upper circuit limit of ₹17.77 and a lower circuit limit of ₹11.85. The total value traded stands at ₹20092.80, and the delivery percentage for the day is 0%.
The stock is currently traded with a market lot size of 1. Venmax Drugs And Pharmaceuticals also offers a dividend yield of 0%.
Venmax Drugs And Pharmaceuticals Share Price Chart
Venmax Drugs And Pharmaceuticals Share Key Metrics
Volume
1380.00
Market Cap
21.00 CR
LTQ@LTP
1@14.76
ATP
14.56
Var Margin
30.55 %
Circuit Range
11.85-17.77
Delivery %
0 %
Value
20092.80
ASM/GSM
No
Market Lot
1
Venmax Drugs And Pharmaceuticals Resistance and Support
Pivot 14.52
Resistance
First Resistance
15.79
Second Resistance
16.77
Third Resistance
18.04
Support
First Support
13.54
Second Support
12.27
Third Support
11.29
Venmax Drugs And Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Oct 01 2026 | 14.99 | 14.76 | -0.34% | 15 | 14.11 |
| Wed Sep 30 2026 | 15.5 | 14.81 | -1.07% | 15.5 | 13.25 |
| Tue Sep 29 2026 | 15 | 14.97 | -1.32% | 15 | 14.06 |
Venmax Drugs And Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-31 | A.G.M. |
| 2026-08-07 | Quarterly Results |
| 2026-05-14 | Audited Results |
| 2026-02-07 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-09-02 | Amalgamation & A.G.M. |
| 2025-08-16 | Others |
| 2025-07-23 | Quarterly Results |
| 2025-05-09 | Audited Results |
| 2025-02-08 | Quarterly Results |
| 2025-01-11 | Preferential issue of shares |
| 2024-11-11 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
Venmax Drugs And Pharmaceuticals News
Venmax Drugs and Pharmaceuticals Ltd - 531015 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Venmax Drugs is holding a meeting of its equity shareholders on October 24, 2026, as per NCLT directions. The meeting will consider and approve a proposed scheme of merger under the Companies Act.
Sep 24 2026 13:52:14
Venmax Drugs and Pharmaceuticals Ltd - 531015 - NCLT Conveying Shareholder Meeting On October 24, 2026 At 12.30 P.M.
Venmax Drugs & Pharmaceuticals will hold an NCLT-convened meeting for equity shareholders on October 24, 2026, via video conference. The agenda is to consider and approve the amalgamation scheme with Hatri Pharma Private Ltd, which aims for business integration and efficiencies.
Sep 22 2026 22:13:21
Read More
Venmax Drugs And Pharmaceuticals Management
| Name | Position |
|---|---|
| Priyanka Agarwal | Company Secretary & Compliance Officer |
| Venkata Rao Sadhanala | Whole Time Director |
Venmax Drugs And Pharmaceuticals Similar Stocks
Tejnaksh Healthcare Ltd.
12.70
-0.40 (3.05%)
Bacil Pharma Ltd.
27.37
1.30 (4.99%)
Ishita Drugs & Industries Ltd.
76.20
2.20 (2.97%)
Emmessar Biotech & Nutrition Ltd.
22.99
-0.75 (3.16%)
Beryl Drugs Ltd.
25.97
0.32 (1.25%)
Sharma East India Hospitals & Medical Research Ltd
87.95
-0.05 (0.06%)
Norris Medicines Ltd.
16.30
-0.85 (4.96%)
Soni Medicare Ltd.
0.00
0.00 (0.00%)
Venmax Drugs And Pharmaceuticals FAQs
The Buying Price of Venmax Drugs And Pharmaceuticals share is 14.76 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Venmax Drugs And Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Venmax Drugs And Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Venmax Drugs And Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Venmax Drugs And Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Venmax Drugs And Pharmaceuticals’s valuation compare Sector P/E, P/B which are 43.03 & 3.62 with sector averages, along with growth rates and financial metrics.
The Market Cap of Venmax Drugs And Pharmaceuticals is 21.00 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Venmax Drugs And Pharmaceuticals share price is 31.49 & 12.71. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Venmax Drugs And Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in VENMAX
